Julio Iglesias-Garcia1, Björn Lindkvist2, Jose Lariño-Noia1, Ihab Abdulkader-Nallib3, J Enrique Dominguez-Muñoz1. 1. Department of Gastroenterology and Instituto de Investigación Sanitaria de Santiago (IDIS), University Hospital of Santiago de Compostela, Santiago de Compostela, Spain. 2. Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 3. Department of Pathology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
Abstract
BACKGROUND: Contrast-enhanced harmonic endoscopic ultrasound (CEH-EUS) and quantitative-elastography endoscopic ultrasound (QE-EUS) are considered useful tools for the evaluation of solid pancreatic tumors (SPT). The aim of our study was to evaluate the diagnostic accuracy of CEH-EUS, QE-EUS, and the combination of both for the differential diagnosis of SPT. METHODS: Sixty-two consecutive patients (mean age 64.3 years, range 32-89 years, 44 male) who underwent EUS for the evaluation of SPT were prospectively included. EUS was performed with a linear Pentax-EUS and a Hitachi-Preirus processor. The mass (area A) and a reference area B were selected during QE-EUS, and results expressed as B/A (strain ratio). A strain histogram of the mass was also evaluated. Microvascularization of the tumor was evaluated over 2 min during CEH-EUS after intravenous injection of 4.8 mL SonoVue. Final diagnosis was based on histopathology of surgical specimens or EUS-guided tissue acquisition and clinical follow-up in non-operated cases. Diagnostic accuracy of CEH-EUS, QE-EUS, and their combination was calculated. RESULTS: Median size of the masses was 32 mm (range 12-111). Final diagnosis was pancreatic adenocarcinoma (n = 45), neuroendocrine tumor (n = 3), inflammatory mass (n = 10), pancreatic metastasis (n = 2), autoimmune pancreatitis (n = 1), and a mucinous cystadenocarcinoma (n = 1). Overall accuracies for determination of malignancy using QE-EUS, CEH-EUS, their combination, and EUS-guided tissue acquisition were 98.4% (95% confidence interval (CI): 91.4-99.7), 85.5% (95% CI: 74.7-92.2), 91.9% (95% CI: 82.5-96.5), and 91.5% (95% CI: 83.6-99.5), respectively. CONCLUSION: The combination of QE-EUS and CEH-EUS is a useful tool for the differential diagnosis of SPT, giving complementary information. However, this combination does not significantly increase the diagnostic accuracy of either of the techniques performed alone.
BACKGROUND: Contrast-enhanced harmonic endoscopic ultrasound (CEH-EUS) and quantitative-elastography endoscopic ultrasound (QE-EUS) are considered useful tools for the evaluation of solid pancreatic tumors (SPT). The aim of our study was to evaluate the diagnostic accuracy of CEH-EUS, QE-EUS, and the combination of both for the differential diagnosis of SPT. METHODS: Sixty-two consecutive patients (mean age 64.3 years, range 32-89 years, 44 male) who underwent EUS for the evaluation of SPT were prospectively included. EUS was performed with a linear Pentax-EUS and a Hitachi-Preirus processor. The mass (area A) and a reference area B were selected during QE-EUS, and results expressed as B/A (strain ratio). A strain histogram of the mass was also evaluated. Microvascularization of the tumor was evaluated over 2 min during CEH-EUS after intravenous injection of 4.8 mL SonoVue. Final diagnosis was based on histopathology of surgical specimens or EUS-guided tissue acquisition and clinical follow-up in non-operated cases. Diagnostic accuracy of CEH-EUS, QE-EUS, and their combination was calculated. RESULTS: Median size of the masses was 32 mm (range 12-111). Final diagnosis was pancreatic adenocarcinoma (n = 45), neuroendocrine tumor (n = 3), inflammatory mass (n = 10), pancreatic metastasis (n = 2), autoimmune pancreatitis (n = 1), and a mucinous cystadenocarcinoma (n = 1). Overall accuracies for determination of malignancy using QE-EUS, CEH-EUS, their combination, and EUS-guided tissue acquisition were 98.4% (95% confidence interval (CI): 91.4-99.7), 85.5% (95% CI: 74.7-92.2), 91.9% (95% CI: 82.5-96.5), and 91.5% (95% CI: 83.6-99.5), respectively. CONCLUSION: The combination of QE-EUS and CEH-EUS is a useful tool for the differential diagnosis of SPT, giving complementary information. However, this combination does not significantly increase the diagnostic accuracy of either of the techniques performed alone.
Authors: Adrian Săftoiu; Sevasti A Iordache; Dan Ionu Gheonea; Carmen Popescu; Anca Maloş; Florin Gorunescu; Tudorel Ciurea; Alexandru Iordache; Gabriel Lucian Popescu; C T Lin Manea Journal: Gastrointest Endosc Date: 2010-08-02 Impact factor: 9.427
Authors: Julio Iglesias-Garcia; J Enrique Dominguez-Munoz; Ihab Abdulkader; Jose Larino-Noia; Elena Eugenyeva; Antonio Lozano-Leon; Jeronimo Forteza-Vila Journal: Am J Gastroenterol Date: 2011-04-12 Impact factor: 10.864
Authors: Michael Hocke; Ewald Schulze; Peter Gottschalk; Theodor Topalidis; Christoph F Dietrich Journal: World J Gastroenterol Date: 2006-01-14 Impact factor: 5.742
Authors: Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy Journal: Cochrane Database Syst Rev Date: 2017-04-17
Authors: Paul E Oberstein; Niloufar Saharkhiz; Thomas Payen; Carmine F Palermo; Stephen A Sastra; Yang Han; Alireza Nabavizadeh; Irina R Sagalovskiy; Barbara Orelli; Vilma Rosario; Deborah Desrouilleres; Helen Remotti; Michael D Kluger; Beth A Schrope; John A Chabot; Alina C Iuga; Elisa E Konofagou; Kenneth P Olive Journal: Clin Cancer Res Date: 2019-12-12 Impact factor: 12.531
Authors: Hexuan Wang; Michael D Nieskoski; Kayla Marra; Jason R Gunn; Stuart B Trembly; Brian W Pogue; Marvin M Doyley Journal: Ultrasound Med Biol Date: 2017-09-28 Impact factor: 2.998